The Role of Combination or Co-formulation Products in the Treatment of Type 2 Diabetes (Home Study)

Activity Preview

Join the APhA-APPM Diabetes Management Special Interest Group for The Role of Combination or Co-formulation Products in the Treatment of Type 2 Diabetes. Learn about combination therapy and co-formulated products in diabetes management, including updates to standards of care, evidence for use, and application in patient care. 

Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Review updates to the 2018 American Diabetes Association Standards of Medical Care in Diabetes related to the use of combination therapy or co-formulated products.
  2. Describe evidence that supports a physiologic approach to treatment intensification using combination therapy or co-formulated products.
  3. Compare and contrast co-formulated injectable products with each individual agent.

Activity type: Knowledge-based

Target Audience: Pharmacists 

Learning Level: 2

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following activity is approved for 1.0 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-18-133-H01-P.

To obtain credit for completing The Role of Combination or Co-formulation Products in the Treatment of Type 2 Diabetes (Home Study), watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript. 

Initial release date: March 7, 2018
Expiration date: March 7, 2021

Development

The Role of Combination or Co-formulation Products in the Treatment of Type 2 Diabetes (Home Study) is an archived, online educational activity for pharmacists developed by the American Pharmacists Association.

Disclosures

Justinne Guyton, PharmD, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures

Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association. 

Fee

There is no fee associated with this activity.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-18-133-H01-P 0.1 CEUs March 07, 2018 - March 07, 2021